Reverse Merger (Tables)

6 Months Ended

Jun. 30, 2014

Business Combinations [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The table below shows the management’s best estimate of the purchase price paid for the reverse acquisition of CytoCore by Medite Enterprise, Inc. :

	In thousands
Net assets acquired
Cash	$	1
Accounts receivable		8
Goodwill		12,461
	$	12,470
Liabilities assumed
Accounts payable & accrued expenses	$	2,908
Related party advances		102
Loans payable		21
	$	3,031
Net identifiable assets/consideration paid	$	9,439